These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7721953)

  • 21. Inhibition of Raf-1 kinase expression abolishes insulin stimulation of DNA synthesis in H4IIE hepatoma cells.
    Törnkvist A; Parpal S; Gustavsson J; Strålfors P
    J Biol Chem; 1994 May; 269(19):13919-21. PubMed ID: 8188671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells.
    Halperin JA; Taratuska A; Nicholson-Weller A
    J Clin Invest; 1993 May; 91(5):1974-8. PubMed ID: 8486768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 regulates normal cardiovascular development and cardiac cellular hypertrophy.
    Yamazaki T; Kurihara H; Kurihara Y; Komuro I; Yazaki Y
    J Card Fail; 1996 Dec; 2(4 Suppl):S7-12. PubMed ID: 8951555
    [No Abstract]   [Full Text] [Related]  

  • 24. Choline kinase: an important target for cancer.
    Janardhan S; Srivani P; Sastry GN
    Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of mitogenesis by water-soluble phospholipid intermediates.
    Kiss Z
    Cell Signal; 1999 Mar; 11(3):149-57. PubMed ID: 10353688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.
    Falcon SC; Hudson CS; Huang Y; Mortimore M; Golec JM; Charlton PA; Weber P; Sundaram H
    Oncogenesis; 2013; 2(3):e38. PubMed ID: 25522435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.
    Lacal JC; Zimmerman T; Campos JM
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.
    Cuadrado A; Carnero A; Dolfi F; Jiménez B; Lacal JC
    Oncogene; 1993 Nov; 8(11):2959-68. PubMed ID: 8414498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
    Hernández-Alcoceba R; Saniger L; Campos J; Núñez MC; Khaless F; Gallo MA; Espinosa A; Lacal JC
    Oncogene; 1997 Nov; 15(19):2289-301. PubMed ID: 9393874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics reveals biomarkers of opioid use disorder.
    Ghanbari R; Li Y; Pathmasiri W; McRitchie S; Etemadi A; Pollock JD; Poustchi H; Rahimi-Movaghar A; Amin-Esmaeili M; Roshandel G; Shayanrad A; Abaei B; Malekzadeh R; Sumner SCJ
    Transl Psychiatry; 2021 Feb; 11(1):103. PubMed ID: 33542199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ChoK-ing the Pathogenic Bacteria: Potential of Human Choline Kinase Inhibitors as Antimicrobial Agents.
    Khalifa M; Few LL; See Too WC
    Biomed Res Int; 2020; 2020():1823485. PubMed ID: 32695809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.
    Sonkar K; Ayyappan V; Tressler CM; Adelaja O; Cai R; Cheng M; Glunde K
    NMR Biomed; 2019 Oct; 32(10):e4112. PubMed ID: 31184789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
    Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
    Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
    Arlauckas SP; Popov AV; Delikatny EJ
    Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomics in rheumatic diseases: desperately seeking biomarkers.
    Guma M; Tiziani S; Firestein GS
    Nat Rev Rheumatol; 2016 May; 12(5):269-81. PubMed ID: 26935283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choline kinase inhibition in rheumatoid arthritis.
    Guma M; Sanchez-Lopez E; Lodi A; Garcia-Carbonell R; Tiziani S; Karin M; Lacal JC; Firestein GS
    Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
    Arlauckas SP; Popov AV; Delikatny EJ
    Mol Cancer Ther; 2014 Sep; 13(9):2149-58. PubMed ID: 25028471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study.
    Al-Saeedi F
    Curr Ther Res Clin Exp; 2007 Jul; 68(4):226-41. PubMed ID: 24683213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis Related to Metastatic Burden Measured by ¹⁸F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer.
    Kwee SA; Lim J; Watanabe A; Kromer-Baker K; Coel MN
    J Nucl Med; 2014 Jun; 55(6):905-10. PubMed ID: 24676753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choline kinase beta is required for normal endochondral bone formation.
    Li Z; Wu G; Sher RB; Khavandgar Z; Hermansson M; Cox GA; Doschak MR; Murshed M; Beier F; Vance DE
    Biochim Biophys Acta; 2014 Jul; 1840(7):2112-22. PubMed ID: 24637075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.